Update on systemic treatment in early triple negative breast cancer

Triple negative breast cancer (TNBC) is a heterogeneous disease representing about 15% of all breast cancers. TNBC are usually high-grade histological tumors, and are generally more aggressive and difficult to treat due to the lack of targeted therapies available, and chemotherapy remains the standa...

Descripción completa

Detalles Bibliográficos
Autores principales: Núñez Abad, Martín, Calabuig-Fariñas, Silvia, Lobo de Mena, Miriam, José Godes Sanz de Bremond, María, García González, Clara, Torres Martínez, Susana, García-García, José Ángel, Iranzo González-Cruz, Vega, Camps Herrero, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871289/
https://www.ncbi.nlm.nih.gov/pubmed/33613695
http://dx.doi.org/10.1177/1758835920986749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871289/
https://www.ncbi.nlm.nih.gov/pubmed/33613695
http://dx.doi.org/10.1177/1758835920986749

Ejemplares similares